Welcome to our dedicated page for APOGEE ENTERPRISES SEC filings (Ticker: APOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on APOGEE ENTERPRISES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into APOGEE ENTERPRISES's regulatory disclosures and financial reporting.
Parker Herbert K reported acquisition or exercise transactions in this Form 4 filing.
APOGEE ENTERPRISES, INC. director Herbert K. Parker received a grant of 2,741 shares of common stock valued at $41.96 per share. The award vests over three years, with one-third vesting on each anniversary of the grant date. Following this grant, he directly holds 16,224 shares, including restricted stock awarded under the 2019 Non-Employee Director Stock Plan.
Wagner Patricia K reported acquisition or exercise transactions in this Form 4 filing.
Apogee Enterprises director Patricia K. Wagner reported a new stock award and updated her holdings. She received a grant of 2,741 shares of common stock at a reference price of $41.96 per share, bringing her directly held common stock to 7,760 shares.
The granted shares vest over three years, with one-third vesting on each anniversary of the grant date, and are made under the company’s 2019 Non-Employee Director Stock Plan. Wagner is also reported as having indirect ownership of 22,558 shares of common stock through a family trust for the benefit of herself and her spouse, where they serve as trustees.
Alvord Christina M reported acquisition or exercise transactions in this Form 4 filing.
APOGEE ENTERPRISES, INC. director Christina M. Alvord received a grant of 2,741 deferred restricted stock units, valued at $41.96 per unit. These units were allocated under the 2019 Non-Employee Director Stock Plan and will be settled in common shares after she leaves the Board or upon specified plan events.
Each deferred restricted stock unit is settled 1-for-1 in common stock. Following this grant, Alvord now holds a total of 13,280 deferred restricted stock units, including amounts accumulated through a dividend equivalent reinvestment feature in the same director stock plan.
APOGEE ENTERPRISES, INC. director Mark A. Pompa received 2,741 deferred restricted stock units as a compensation award, valued at $41.96 per unit. These units convert 1-for-1 into common shares and will be settled after he leaves the board or upon other plan-specified events, bringing his total deferred units to 27,581.
Apogee Enterprises director Lilly Elizabeth Murphy received a grant of 2,741 Deferred Restricted Stock Units under the 2019 Non-Employee Director Stock Plan at a reference price of $41.96 per unit. Each unit will convert 1-for-1 into common stock, generally after her Board service ends, bringing her total deferred units to 9,641.
Apogee Enterprises reported first-quarter fiscal 2027 results showing stronger profitability on slightly lower sales. Net sales were $342.7 million, down 1.1% from a year ago, but operating income rose to $18.8 million and net earnings reached $11.5 million versus a prior loss. Diluted EPS improved to $0.54, with adjusted diluted EPS of $0.57, essentially flat year over year. Gross margin edged up to 21.9% and SG&A fell to 16.4% of sales, reflecting cost savings from Project Fortify Phase 2. Cash from operating activities was $7.4 million, and the company returned $15.3 million through dividends and share repurchases. Apogee reaffirmed its fiscal 2027 guidance for net sales of $1.38–$1.43 billion and adjusted EPS of $2.70–$3.25, and expects its pending Kalwall acquisition to close in early July and be accretive to adjusted EPS.
APOG Holdings filed a Form 144 reporting proposed sales of Common Stock. The filing lists a tranche of 10,148 (entry shown) and a dollar figure of 405,920.00 on the same line. The filing also lists multiple restricted stock vesting entries of 5,622, 2,050, 558 and 1,918 shares with their respective vesting dates.
Apogee Enterprises, Inc. announced that Brent C. Jewell has resigned as President of its Architectural Glass Segment. The resignation was tendered on May 26, 2026, and his last day with the company will be June 10, 2026.
The company states that his resignation is unrelated to the transaction it announced on May 28, 2026 and did not result from any disagreement over operations, policies, or practices. Jewell is expected to continue supporting transition, pre-closing, and integration activities related to that transaction through his final date of employment.
Apogee Enterprises, Inc. has entered into a definitive agreement to acquire Keller Companies, Inc., the controlling owner of Kalwall Corporation and Structures Unlimited Inc., for approximately $105 million in cash at closing plus up to $10 million in earn-out payments. The deal includes related real estate purchases and will make KCI a wholly owned subsidiary, financed with cash on hand and the company’s existing credit facility.
The transaction is subject to customary closing conditions, has no financing contingency, and is expected to close in Apogee’s fiscal 2027 second quarter. Apogee plans to integrate Kalwall into its Architectural Glass segment and projects about $85 million of revenue in the first 12 months, an adjusted EBITDA margin of roughly 15% initially and a long-term target of 20%. Management also anticipates $4 million of annual operational cost synergies by the end of fiscal 2029 and expects the deal to be accretive to adjusted diluted EPS in the first year.